Cardiac Risk in Patients with Treatment Naïve, First-Line Medically Controlled and First-Line Surgically Cured Acromegaly in Comparison to Matched Data from the General Population-Reference-Cited by-同舟云学术

Cardiac Risk in Patients with Treatment Naïve, First-Line Medically Controlled and First-Line Surgically Cured Acromegaly in Comparison to Matched Data from the General Population

Published:2013-01-21 Issue:02 Volume:121 Page:125-132
ISSN:0947-7349
Container-title:Experimental and Clinical Endocrinology & Diabetes
language:en
Short-container-title:Exp Clin Endocrinol Diabetes

Author:

Berg C.¹,Petersenn S.¹,Walensi M.¹,Möhlenkamp S.²,Bauer M.²,Lehmann N.³,Roggenbuck U.³,Moebus S.³,Broecker-Preuss M.¹,Sandalcioglu I.⁴,Stolke D.⁴,Sure U.⁴,Joeckel K.³,Erbel R.²,Führer D.¹,Mann K.¹,

Affiliation:

1. Department of Endocrinology and Metabolism and Division of Laboratory Research, University Hospital of Essen, University of Duisburg-Essen, Germany

2. Department of Cardiology, West-German Heart Centre Essen, University Hospital of Essen, University of Duisburg-Essen, Germany

3. Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, University Duisburg-Essen, Germany

4. Department of Neurosurgery, University Hospital of Essen, University of Duisburg-Essen, Germany

Publisher

Georg Thieme Verlag KG

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0032-1314811.pdf

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines;Pituitary;2023-05-20

2. Serum NT-pro-BNP Levels Predict Cardiovascular Events in Acromegaly Patients;Experimental and Clinical Endocrinology & Diabetes;2021-12-23

3. Impact of obstructive sleep apnea on cardiovascular risk in patients with acromegaly;Sleep Medicine;2021-04

4. Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature;Endocrine;2018-11-05

5. Risk of left ventricular hypertrophy and diastolic and systolic dysfunction in Acromegaly: A meta-analysis;Journal of Clinical Neuroscience;2018-02